|
|
|
Volumn 23, Issue 3 SUPPL. 6, 1996, Pages 33-37
|
|
Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CYCLOPHOSPHAMIDE DERIVATIVE;
ETOPOSIDE;
IFOSFAMIDE;
CANCER CHEMOTHERAPY;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SCREENING;
HUMAN;
NEPHROTOXICITY;
NEUROTOXICITY;
NONHODGKIN LYMPHOMA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW TRANSPLANTATION;
CARBOPLATIN;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
DISEASE-FREE SURVIVAL;
ETOPOSIDE;
HUMANS;
IFOSFAMIDE;
LYMPHOMA, NON-HODGKIN;
SALVAGE THERAPY;
TRANSPLANTATION, AUTOLOGOUS;
|
|
EID: 0029955676
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (10)
|
|
References (0)
|
